These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20148708)

  • 1. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
    Goyanes A; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to developing fast release pellets via wet extrusion-spheronization.
    Xia Y; Shi CY; Fang JG; Wang WQ
    Pharm Dev Technol; 2018 Jun; 23(5):432-441. PubMed ID: 27882815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of non-ionic surfactants on the rheological properties of drug/microcrystalline cellulose/water mixtures and their use in the preparation and drug release performance of pellets prepared by extrusion/spheronization.
    Podczeck F; Maghetti A; Newton JM
    Eur J Pharm Sci; 2009 Jun; 37(3-4):334-40. PubMed ID: 19491024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets.
    Goyanes A; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2011 Jul; 37(7):825-31. PubMed ID: 21405942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization.
    Souto C; Rodríguez A; Parajes S; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):94-9. PubMed ID: 15967651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of wetting, drying, and microcrystalline cellulose type on the mechanical strength and disintegration of pellets.
    Balaxi M; Nikolakakis I; Kachrimanis K; Malamataris S
    J Pharm Sci; 2009 Feb; 98(2):676-89. PubMed ID: 18548618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW; Koo OM
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.